A Randomized, Double-Blind, Double-Dummy, Multi-Centre, 4-Way Cross-Over Study to Compare the Single Dose Bronchodilatory Effect of Formoterol Fumarate in Combination With Mometasone Furoate Delivered Via Pressurized Metered Dose Inhaler (pMDI) to Placebo Delivered Via pMDI in Children Aged 5-11 Years Old With Persistent Asthma.
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2011
At a glance
- Drugs Formoterol; Mometasone/formoterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Novartis
- 07 Jun 2017 Biomarkers information updated
- 13 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.